Elixir Pharmaceuticals, Inc. went out of business. Elixir Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes pharmaceuticals for the treatment of metabolic diseases. It develops small molecule drugs that mimic longevity responses, as well as used to treat a rang... Elixir Pharmaceuticals, Inc. went out of business. Elixir Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes pharmaceuticals for the treatment of metabolic diseases. It develops small molecule drugs that mimic longevity responses, as well as used to treat a range of age-related diseases, including diabetes and obesity. The company’s products include Metgluna and Glinsuna for the treatment of type 2 diabetes; Ghrelin, an oral antagonist for the treatment of metabolic diseases; and EX-1314, an oral drug developed for the treatment of type 1 diabetic gastroparesis. It has strategic alliances/partnerships with Kissei Pharmaceuticals, Bristol-Myers Squibb, Siena Biotech S.p.A., and Novartis Pharmaceuticals. The company was founded in 1999 and is headquartered in Cambridge, Massachusetts. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Steady_T
5分前
Jaguarjacket
12分前
Achilles deFlandres
14分前
Gravedigger1
17分前
Split T
21分前
dinogreeves
21分前
Mr. C
24分前
dinogreeves
26分前
tootalljones
43分前
knrorrel
48分前
Genz2
49分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。